Ergoteles LLC Nkarta, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.14 - $14.35 $149,306 - $416,838	29,048 New	29,048 $173,000
Q2 2022 Aug 12, 2022	SELL	$7.77 - $19.44 $109,557 - $274,104	-14,100 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.66 - $14.99 $64,084 - $110,926	-7,400 Reduced 34.42%	14,100 $160,000
Q4 2021 Feb 14, 2022	BUY	$12.79 - $26.88 $274,985 - $577,920	21,500 New	21,500 $330,000
Q3 2021 Nov 15, 2021	SELL	$26.67 - $38.76 $866,775 - $1.26 Million	-32,500 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$23.94 - $36.68 $778,050 - $1.19 Million	32,500 New	32,500 $1.03 Million

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.